Bought at £1.19.
I read an excellent blog post on 4D Pharma by Shrey Srivastava which led me to research this company further. This can be found here.
The key for me is the fact there are 16 products in the pipeline. The risk with any pharma company is that the product fails during the R&D stages. Having this many products significantly mitigates against that risk. The large quantity of patents the company also owns further safeguards their products.
24 December 2020